Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk
Open accessAbstract
Aims/hypothesis The aim of the study was to investigate the timing of the appearance of autoantibodies associated with type 1 diabetes between birth and puberty, the natural fate of these autoantibodies and the predictive power of autoantibody concentrations for early progression to clinical diabetes. Methods Children were recruited to the Type 1 Diabetes Prediction and Prevention Project, an ongoing study based on HLA-conferred genetic risk. Autoantibodies against islet cells, insulin, GAD65 and islet antigen 2 were analysed at 3-12 month intervals, starting from birth. Results During the follow-up, 1,320 children (18.4% of the cohort of 7,165 children) were autoantibody positive in at least one sample. Altogether, 184 autoantibody-positive children progressed to type 1 diabetes. Seroconversion occurred at an early age in the progressors (median 1.5 years), among whom 118 (64%) and 150 (82%) seroconverted to autoantibody positivity before the age of 2 and 3 years, respectively. The incidence of seroconversion peaked at 1 year of age. Compared with other autoantibody-positive children, the median autoantibody levels were already markedly higher 3 to 6 months after the seroconversion in children who later progressed to diabetes. Conclusions/interpretation Early initiation of autoimmunity and rapid increases in autoantibody titres strongly predict progression to overt diabetes before puberty, emphasising the importance of early life events in the development of type 1 diabetes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
IAA concentration correlates with the rate of progression to overt type 1 diabetes in children followed from birth.
“IAA concentration correlates with the rate of progression to overt type 1 diabetes in children followed from birth.67,68”
From Type 1 diabetes (2014) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Christakis, D., Richards, J. A., Zimmerman, F. J., Garrison, M. M., Xu, D., & Yapanel, U. H. (2009) · Cited by 2,290 · see citing works
Patterson, C. C., Dahlquist, G. G., Gyürüs, E., Green, A., & Soltész, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60568-7 · Cited by 1,854 · see citing works
The Type 1 Diabetes Genetics Consortium, Barrett, J. C., Clayton, D. G., Concannon, P., Akolkar, B., Cooper, J. D., Erlich, H. A., Julier, C., Morahan, G., Nerup, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.381 · Cited by 1,746 · see citing works
ISLET-CELL ANTIBODIES IN DIABETES MELLITUS WITH AUTOIMMUNE POLYENDOCRINE DEFICIENCIES
Bottazzo, G., Florin-Christensen, A., & Doniach, D. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90140-8 · Cited by 1,469 · see citing works
Incidence and trends of childhood type 1 diabetes worldwide 1990–1999
The DIAMOND Project Group (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01925.x · Cited by 1,085 · see citing works
Onkamo, P., Väänänen, S., Karvonen, M., & Tuomilehto, J. O. (1999) · Diabetologia · doi:10.1007/s001250051309 · Cited by 886 · see citing works
Verge, C. F., Gianani, R., Kawasaki, E., Yu, L., Pietropaolo, M., Chase, H. P., Eisenbarth, G. S., & Jackson, R. A. (1996) · Diabetes · doi:10.2337/diab.45.7.926 · Cited by 827 · see citing works
Termination of Pregnancy on Psychiatric Grounds
Graham-Stewart, C. W. (1964) · The Lancet · doi:10.1016/s0140-6736(64)92746-1 · Cited by 681 · see citing works
Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study
Harjutsalo, V., Sjöberg, L., & Tuomilehto, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60765-5 · Cited by 666 · see citing works
Ziegler, A., Hummel, M., Schenker, M., & Bonifacio, E. E. (1999) · Diabetes · doi:10.2337/diabetes.48.3.460 · Cited by 640 · see citing works
Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A
Nejentsev, S., Howson, J. M. M., Walker, N. M., Szeszko, J. S., Field, S. F., Stevens, H. E., Reynolds, P., Hardy, M. P., King, E., Masters, J., et al. (2007) · Nature · doi:10.1038/nature06406 · Cited by 568 · see citing works
Environmental Triggers and Determinants of Type 1 Diabetes
Knip, M., Veijola, R., Virtanen, S. M., Hyöty, H., Vaarala, O., & Åkerblom, H. K. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s125 · Cited by 496 · see citing works
Self-citationOrešič, M., Simell, S., Sysi-Aho, M., Näntö-Salonen, K., Seppänen-Laakso, T., Parikka, V., Katajamaa, M., Hekkala, A., Mattila, I., Keskinen, P., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081800 · Cited by 449 · see citing works
Self-citationBingley, P. J., Christie, M. R., Bonifacio, E. E., Bonfanti, R., Shattock, M., Fonte, M.-T., Bottazzo, G.-F., & Gale, E. A. (1994) · Diabetes · doi:10.2337/diab.43.11.1304 · Cited by 384 · see citing works
Näntö-Salonen, K., Kupila, A., Simell, S., Siljander, H., Salonsaari, T., Hekkala, A., Korhonen, S., Erkkola, R., Sipilä, J. I., Haavisto, L., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61309-4 · Cited by 382 · see citing works
Self-citationBarker, J. M., Barriga, K. J., Yu, L., Miao, D., Erlich, H. A., Norris, J. M., Eisenbarth, G. S., & Rewers, M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031887 · Cited by 348 · see citing works
Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes
Bonifacio, E. E., Shattock, M., Dean, B. M., Bottazzo, G. F., Bingley, P. J., Gale, E., & Dunger, D. B. (1990) · The Lancet · doi:10.1016/0140-6736(90)90013-u · Cited by 344 · see citing works
Autoimmune type 1 diabetes: resolved and unresolved issues
Notkins, A. L., & Lernmark, Å. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14257 · Cited by 322 · see citing works
The Environmental Determinants of Diabetes in the Young (TEDDY) Study
TEDDY Study Group (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1447.062 · Cited by 310 · see citing works
Gillespie, K. M., Bain, S. C., Barnett, A. H., Bingley, P. J., Christie, M. R., Gill, G. V., & Gale, E. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17357-1 · Cited by 304 · see citing works
Kulmala, P., Savola, K., Petersen, J. S., Vähäsalo, P., Karjalainen, J., Löppönen, T., Dyrberg, T., Åkerblom, H. K., & Knip, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119879 · Cited by 284 · see citing works
Self-citationStratification of Type 1 Diabetes Risk on the Basis of Islet Autoantibody Characteristics
Achenbach, P., Warncke, K., Reiter, J., Naserke, H. E., Williams, A. J. K., Bingley, P. J., Bonifacio, E. E., & Ziegler, A. (2004) · Diabetes · doi:10.2337/diabetes.53.2.384 · Cited by 276 · see citing works
Genetic analysis of type 1 diabetes using whole genome approaches.
Todd, J. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8560 · Cited by 253 · see citing works
Gardner, S., Bingley, P. J., Sawtell, P., Weeks, S., & Gale, E. A. (1997) · BMJ · doi:10.1136/bmj.315.7110.713 · Cited by 240 · see citing works
Lambert, A. P., Gillespie, K. M., Thomson, G. J., Cordell, H. J., Todd, J. A., Gale, E. A., & Bingley, P. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032084 · Cited by 240 · see citing works
A Novel Micro-assay for Insulin Autoantibodies
Williams, A. J. K., Bingley, P. J., Bonifacio, E. E., Palmer, J. P., & Gale, E. A. (1997) · Journal of Autoimmunity · doi:10.1006/jaut.1997.0154 · Cited by 238 · see citing works
Steck, A. K., Johnson, K., Barriga, K. J., Miao, D., Yu, L., Hutton, J. C., Eisenbarth, G. S., & Rewers, M. J. (2011) · Diabetes Care · doi:10.2337/dc10-2088 · Cited by 195 · see citing works
IA-2 antibodies - a sensitive marker of IDDM with clinical onset in childhood and adolescence
Savola, K., Bonifacio, E. E., Sabbah, E., Kulmala, P., Vähäsalo, P., Karjalainen, J., Tuomilehto‐Wolf, E., Meriläinen, J., Åkerblom, H. K., & Knip, M. (1998) · Diabetologia · doi:10.1007/s001250050925 · Cited by 186 · see citing works
Self-citationKarvonen, M., Pitkäniemi, J. M., & Tuomilehto, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.7.1066 · Cited by 171 · see citing works
Triple-label hybridization assay for type-1 diabetes-related HLA alleles.
Sjöroos, M., Iitiä, A., Ilonen, J., Reijonen, H., & Lövgren, T. N.-E. (1995) · PubMed · Cited by 165 · see citing works
Self-citationNejentsev, S., Sjöroos, M., Soukka, T., Knip, M., Simell, O., Lövgren, T. N.-E., & Ilonen, J. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00186.x · Cited by 164 · see citing works
Self-citationAutoantibodies associated with Type I diabetes mellitus persist after diagnosis in children
Savola, K., Sabbah, E., Kulmala, P., Vähäsalo, P., Ilonen, J., & Knip, M. (1998) · Diabetologia · doi:10.1007/s001250051067 · Cited by 161 · see citing works
Self-citationPrediction of Type 1 Diabetes in the General Population
Knip, M., Korhonen, S., Kulmala, P., Veijola, R., Reunanen, A., Raitakari, O. T., Viikari, J. S. A., & Åkerblom, H. K. (2010) · Diabetes Care · doi:10.2337/dc09-1040 · Cited by 141 · see citing works
Self-citationIlonen, J., Reijonen, H., Herva, E., Sjöroos, M., Iitiä, A., Lövgren, T. N.-E., Veijola, R., Knip, M., Åkerblom, H. K., & The Childhood Diabetes in Finland (DIME) Study Group (1996) · Diabetes Care · doi:10.2337/diacare.19.8.795 · Cited by 137 · see citing works
Self-citationSiljander, H., Simell, S., Hekkala, A., Lähde, J., Simell, T. T., Vähäsalo, P., Veijola, R., Ilonen, J., Simell, O., & Knip, M. (2009) · Diabetes · doi:10.2337/db08-1305 · Cited by 133 · see citing works
Self-citationKeskinen, P., Korhonen, S., Kupila, A., Veijola, R., Erkkilä, S., Savolainen, H., Arvilommi, P., Simell, T. T., Ilonen, J., Knip, M., et al. (2002) · Diabetologia · doi:10.1007/s00125-002-0981-8 · Cited by 89 · see citing works
Self-citationEstimation of genetic risk for type 1 diabetes
Ilonen, J., Sjöroos, M., Knip, M., Veijola, R., Simell, O., Åkerblom, H. K., Paschou, P., Bozas, E., Havarani, B., Malamitsi‐Puchner, A., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10341 · Cited by 80 · see citing works
Self-citationLipponen, K., Gombos, Z., Kiviniemi, M., Siljander, H., Lempainen, J., Hermann, R., Veijola, R., Simell, O., Knip, M., & Ilonen, J. (2010) · Diabetes · doi:10.2337/db10-0167 · Cited by 54 · see citing works
Self-citationPregnancy induces nonimmunoglobulin insulin-binding activity in both maternal and cord blood serum
Ronkainen, M. S., Hämäläinen, A.-M., Koskela, P. U., Åkerblom, H. K., & Knip, M. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01506.x · Cited by 47 · see citing works
Self-citationIncreasing incidence of Type 1 diabetes – role for genes?
Pitkäniemi, J. M., Onkamo, P., Tuomilehto, J., & Arjas, E. (2004) · BMC Genetics · doi:10.1186/1471-2156-5-5 · Cited by 44 · see citing works
Sosenko, J. M., Skyler, J. S., Palmer, J. P., Krischer, J. P., Cuthbertson, D. D., Yu, L., Schatz, D., Orban, T., Eisenbarth, G. S., & Groups, D. P. T. 1. A. T. 1. D. T. S. (2011) · Diabetes Care · doi:10.2337/dc11-0981 · Cited by 43 · see citing works
Thivolet, C. H., Beaufr�re, B., Geburher, L., Chatelain, P., Orgiazzi, J., & Fran�ois, R. (1991) · Diabetologia · doi:10.1007/bf00418274 · Cited by 29 · see citing works
Flagged first, then by citations
1 of the 43 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
2. Classification and Diagnosis of Diabetes: <i>Standards of Medical Care in Diabetes—2022</i>
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792 · see citing works
2. Classification and Diagnosis of Diabetes: <i>Standards of Medical Care in Diabetes—2021</i>
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116 · see citing works
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,713 · see citing works
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D. M., et al. (2022) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,652 · see citing works
2. Diagnosis and Classification of Diabetes: <i>Standards of Care in Diabetes—2024</i>
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086 · see citing works
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393 · see citing works
Insel, R. A., Dunne, J. L., Atkinson, M. A., Chiang, J. L., Dabelea, D., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Krischer, J. P., Lernmark, Å., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1419 · Cited by 1,216 · see citing works
Differentiation of diabetes by pathophysiology, natural history, and prognosis
Skyler, J. S., Bakris, G. L., Bonifacio, E., Darsow, T., Eckel, R. H., Groop, L., Groop, P.-H., Handelsman, Y., Insel, R. A., Mathieu, C., et al. (2017) · Diabetes · doi:10.2337/db16-0806 · Cited by 823 · see citing works
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s002 · Cited by 473 · see citing works
The role of the intestinal microbiota in type 1 diabetes mellitus
Knip, M., & Siljander, H. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.218 · Cited by 434 · see citing works
Self-citationDavis‐Richardson, A. G., Ardissone, A. N., Dias, R., Simell, V., Leonard, M. T., Kemppainen, K. M., Drew, J. C., Schatz, D., Atkinson, M. A., Kolaczkowski, B. D., et al. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00678 · Cited by 313 · see citing works
Self-citationScreening for Type 1 Diabetes in the General Population: A Status Report and Perspective
Sims, E. K., Besser, R. E. J., Dayan, C. M., Rasmussen, C. G., Greenbaum, C. J., Griffin, K., Hagopian, W., Knip, M., Long, A. E., Martin, F., et al. (2022) · Diabetes · doi:10.2337/dbi20-0054 · Cited by 263 · see citing works
Self-citationPatterns of β-Cell Autoantibody Appearance and Genetic Associations During the First Years of Life
Ilonen, J., Hammais, A., Laine, A., Lempainen, J., Vaarala, O., Veijola, R., Simell, O., & Knip, M. (2013) · Diabetes · doi:10.2337/db13-0300 · Cited by 206 · see citing works
Self-citationEnvironmental Triggers of Type 1 DiabetesPreprint
Knip, M., & Simell, O. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007690 · Cited by 206 · see citing works
Self-citationPredicting Type 1 Diabetes Using Biomarkers
Bonifacio, E. E. (2015) · Diabetes Care · doi:10.2337/dc15-0101 · Cited by 191 · see citing works
Raab, J., Haupt, F., Scholz, M., Matzke, C., Warncke, K., Lange, K., Assfalg, R., Weininger, K., Wittich, S., Löbner, S., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011144 · Cited by 145 · see citing works
The Influence of the Microbiome on Type 1 Diabetes
Paun, A., Yau, C., & Danska, J. S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601519 · Cited by 125 · see citing works
Frazzei, G., van Vollenhoven, R., de Jong, B. A., Siegelaar, S. E., & van Schaardenburg, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.899372 · Cited by 125 · see citing works
Type 1 diabetes: A predictable disease
Simmons, K. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.380 · Cited by 119 · see citing works
Prediction and Prevention of Type 1 Diabetes
Primavera, M., Giannini, C., & Chiarelli, F. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00248 · Cited by 112 · see citing works
The prenatal environment and type 1 diabetes
Stene, L. C., & Gale, E. (2013) · Diabetologia · doi:10.1007/s00125-013-2929-6 · Cited by 95 · see citing works
Care of diabetes in children and adolescents: controversies, changes, and consensus
Cameron, F. J., & Wherrett, D. K. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60971-0 · Cited by 99 · see citing works
Wherrett, D. K., Chiang, J. L., Delamater, A. M., DiMeglio, L. A., Gitelman, S. E., Gottlieb, P. A., Herold, K. C., Lovell, D. J., Orchard, T. J., Ryan, C. M., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1429 · Cited by 94 · see citing works
Bravis, V., Kaur, A., Walkey, H. C., Godsland, I. F., Misra, S., Bingley, P. J., Williams, A. J. K., Dunger, D. B., Dayan, C. M., Peakman, M., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020904 · Cited by 91 · see citing works
Beyerlein, A., Wehweck, F. S., Ziegler, A., & Pflueger, M. (2013) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2013.158 · Cited by 90 · see citing works
Cord Serum Lipidome in Prediction of Islet Autoimmunity and Type 1 Diabetes
Orešič, M., Gopalacharyulu, P. V., Mykkänen, J., Lietzén, N., Mäkinen, M., Nygrén, H., Simell, S., Simell, V., Hyöty, H., Veijola, R., et al. (2013) · Diabetes · doi:10.2337/db13-0159 · Cited by 89 · see citing works
Self-citationIslet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes
Giannopoulou, E. Z., Winkler, C., Chmiel, R., Matzke, C., Scholz, M., Beyerlein, A., Achenbach, P., Bonifacio, E. E., & Ziegler, A. (2015) · Diabetologia · doi:10.1007/s00125-015-3672-y · Cited by 87 · see citing works
HbA1c Predicts Time to Diagnosis of Type 1 Diabetes in Children at Risk
Helminen, O., Aspholm, S., Pokka, T. M.-L., Hautakangas, M., Haatanen, N., Lempainen, J., Ilonen, J., Simell, O., Knip, M., & Veijola, R. (2014) · Diabetes · doi:10.2337/db14-0497 · Cited by 85 · see citing works
Self-citationAchenbach, P., Hummel, M., Thümer, L., Boerschmann, H., Höfelmann, D., & Ziegler, A. G. (2013) · Diabetologia · doi:10.1007/s00125-013-2896-y · Cited by 76 · see citing works
Mäkinen, M., Mykkänen, J., Koskinen, M. K., Simell, V., Veijola, R., Hyöty, H., Ilonen, J., Knip, M., Simell, O., & Toppari, J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3504 · Cited by 76 · see citing works
Self-citationAdvances in Type 1 Diabetes Prediction Using Islet Autoantibodies: Beyond a Simple Count
So, M., Speake, C., Steck, A. K., Lundgren, M., Colman, P. G., Palmer, J. P., Herold, K. C., & Greenbaum, C. J. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab013 · Cited by 72 · see citing works
Antvorskov, J. C., Halldorsson, T. I., Josefsen, K. E., Svensson, J., Granström, C., Roep, B. O., Olesen, T. H., Hrólfsdóttir, L., Buschard, K., & Olsen, S. F. (2018) · BMJ · doi:10.1136/bmj.k3547 · Cited by 73 · see citing works
the Type 1 Diabetes TrialNet Study Group, Bingley, P. J., Boulware, D. C., & Krischer, J. P. (2015) · Diabetologia · doi:10.1007/s00125-015-3830-2 · Cited by 72 · see citing works
A divergent population of autoantigen-responsive CD4+T cells in infants prior to β cell autoimmunity
Heninger, A., Eugster, A., Kuehn, D., Buettner, F., Kühn, M., Lindner, A., Dietz, S., Jergens, S., Wilhelm, C., Beyerlein, A., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf8848 · Cited by 72 · see citing works
Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays
Bian, X., Wallstrom, G. L., Davis, A., Wang, J., Park, J., Throop, A. L., Steel, J., Yu, X., Wasserfall, C. H., Schatz, D., et al. (2015) · Diabetes · doi:10.2337/db15-0179 · Cited by 71 · see citing works
Harmonization of immunoassays for biomarkers in diabetes mellitus
Hörber, S., Achenbach, P., Schleicher, E. D., & Peter, A. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.02.015 · Cited by 71 · see citing works
Pathogenesis of type 1 diabetes: lessons from natural history studies of high‐risk individuals
Nokoff, N., & Rewers, M. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12021 · Cited by 66 · see citing works
Ziegler, A., Danne, T., Dunger, D. B., Berner, R., Puff, R., Kiess, W., Agiostratidou, G., Todd, J. A., & Bonifacio, E. E. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.02.003 · Cited by 67 · see citing works
TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes
REDONDO, M. J., Geyer, S. M., Steck, A. K., Sosenko, J. M., Anderson, M. S., Antinozzi, P. A., Michels, A. W., Wentworth, J. M., Xu, P., Pugliese, A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-0961 · Cited by 65 · see citing works
Current understanding of the role of gut dysbiosis in type 1 diabetes
Abdellatif, A. M., & Sarvetnick, N. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12915 · Cited by 64 · see citing works
Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years
Pöllänen, P. M., Ryhänen, S. J., Toppari, J., Ilonen, J., Vähäsalo, P., Veijola, R., Siljander, H., & Knip, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa624 · Cited by 64 · see citing works
Self-citationBosi, E., Boulware, D. C., Becker, D. J., Buckner, J. H., Geyer, S. M., Gottlieb, P. A., Henderson, C., Kinderman, A., Sosenko, J. M., Steck, A. K., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00569 · Cited by 64 · see citing works
Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial
Assfalg, R., Knoop, J., Hoffman, K. L., Pfirrmann, M., Zapardiel‐Gonzalo, J., Hofelich, A., Eugster, A., Weigelt, M., Matzke, C., Reinhardt, J., et al. (2021) · Diabetologia · doi:10.1007/s00125-020-05376-1 · Cited by 64 · see citing works
Winkler, C., Haupt, F., Heigermoser, M., Zapardiel‐Gonzalo, J., Ohli, J., Faure, T., Kalideri, E., Hommel, A., Delivani, P., Berner, R., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12870 · Cited by 62 · see citing works
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention
Carré, A., Vecchio, F., Flodström‐Tullberg, M., You, S., & Mallone, R. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad007 · Cited by 62 · see citing works
Birth and coming of age of islet autoantibodies
Bonifacio, E. E., & Achenbach, P. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13360 · Cited by 58 · see citing works
OGTT and random plasma glucose in the prediction of type 1 diabetes and time to diagnosis
Helminen, O., Aspholm, S., Pokka, T. M.-L., Ilonen, J., Simell, O., Veijola, R., & Knip, M. (2015) · Diabetologia · doi:10.1007/s00125-015-3621-9 · Cited by 57 · see citing works
Self-citationA novel LIPS assay for insulin autoantibodies
Liberati, D., Wyatt, R. C., Brigatti, C., Marzinotto, I., Ferrari, M., Bazzigaluppi, E., Bosi, E., Gillard, B. T., Gillespie, K. M., Gorus, F., et al. (2018) · Acta Diabetologica · doi:10.1007/s00592-017-1082-y · Cited by 57 · see citing works
Bonifacio, E. E., Weiß, A., Winkler, C., Hippich, M., Rewers, M., Toppari, J., Lernmark, Å., She, J., Hagopian, W., Krischer, J. P., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2122 · Cited by 54 · see citing works
Self-citationViruses and Type 1 Diabetes: From Enteroviruses to the Virome
Isaacs, S. R., Foskett, D. B., Maxwell, A. J., Ward, E. J., Faulkner, C. L., Luo, J. Y. X., Rawlinson, W. D., Craig, M. E., & Kim, K. W. (2021) · Microorganisms · doi:10.3390/microorganisms9071519 · Cited by 51 · see citing works
Roles of Commensal Microbiota in Pancreas Homeostasis and Pancreatic Pathologies
Leal‐Lopes, C., Velloso, F. J., Campopiano, J. C., Sogayar, M. C., & Correa, R. G. (2015) · Journal of Diabetes Research · doi:10.1155/2015/284680 · Cited by 52 · see citing works
Disease-Modifying Therapies in Type 1 Diabetes: A Look into the Future of Diabetes Practice
Greenbaum, C. J., VanBuecken, D., & Lord, S. M. (2019) · Drugs · doi:10.1007/s40265-018-1035-y · Cited by 55 · see citing works
Reduced β-cell function in early preclinical type 1 diabetes
Koskinen, M. K., Helminen, O., Matomäki, J., Aspholm, S., Mykkänen, J., Mäkinen, M., Simell, V., Vähä-Mäkilä, M., Simell, T. T., Ilonen, J., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0674 · Cited by 49 · see citing works
Self-citationPöllänen, P. M., Lempainen, J., Laine, A., Toppari, J., Veijola, R., Vähäsalo, P., Ilonen, J., Siljander, H., & Knip, M. (2017) · Diabetologia · doi:10.1007/s00125-017-4258-7 · Cited by 51 · see citing works
Self-citationFelton, J. L., REDONDO, M. J., Oram, R. A., Speake, C., Long, S. A., Önengüt-Gümüşcü, S., Rich, S. S., Monaco, G. S. F., Harris-Kawano, A., Perez, D., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00478-y · Cited by 62 · see citing works
Chmiel, R., Giannopoulou, E. Z., Winkler, C., Achenbach, P., Ziegler, A., & Bonifacio, E. E. (2014) · Diabetologia · doi:10.1007/s00125-014-3443-1 · Cited by 50 · see citing works
General population screening for type 1 diabetes
Insel, R. A., Dunne, J. L., & Ziegler, A. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000173 · Cited by 48 · see citing works
Deciphering early development of complex diseases by progressive module network
Zeng, T., Zhang, C.-C., Zhang, W., Liu, R., Liu, J., & Chen, L. (2014) · Methods · doi:10.1016/j.ymeth.2014.01.021 · Cited by 46 · see citing works
Xu, P., Krischer, J. P., & on behalf of the Type 1 Diabetes TrialNet Study Group (2016) · Diabetes Care · doi:10.2337/dc15-2292 · Cited by 46 · see citing works
Endesfelder, D., zu Castell, W., Bonifacio, E. E., Rewers, M., Hagopian, W., She, J., Lernmark, Å., Toppari, J., Vehik, K., Williams, A. J. K., et al. (2018) · Diabetes · doi:10.2337/db18-0594 · Cited by 45 · see citing works
Self-citationGeneral population screening for childhood type 1 diabetes: is it time for a UK strategy?
Besser, R. E. J., Ng, S. M., Gregory, J. W., Dayan, C. M., Randell, T. L., & Barrett, T. G. (2021) · Archives of Disease in Childhood · doi:10.1136/archdischild-2021-321864 · Cited by 45 · see citing works
Bauer, W., Veijola, R., Lempainen, J., Kiviniemi, M., Härkönen, T., Toppari, J., Knip, M., Gyenesei, A., & Ilonen, J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00421 · Cited by 41 · see citing works
Self-citationHelminen, O., Pokka, T. M.-L., Tossavainen, P. H., Ilonen, J., Knip, M., & Veijola, R. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.07.027 · Cited by 41 · see citing works
Self-citationDysregulation of glucose metabolism in preclinical type 1 diabetes
Veijola, R., Koskinen, M. K., Helminen, O., & Hekkala, A. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12392 · Cited by 41 · see citing works
Self-citationCommon ground: shared risk factors for type 1 diabetes and celiac disease
Verdu, E. F., & Danska, J. S. (2018) · Nature Immunology · doi:10.1038/s41590-018-0130-2 · Cited by 39 · see citing works
Eisenbarth, G. S., & Buse, J. B. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00032-8 · Cited by 39 · see citing works
Screening and Prevention of Type 1 Diabetes: Where Are We?
Simmons, K. M., & Sims, E. K. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad328 · Cited by 39 · see citing works
SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood
Lugar, M., Eugster, A., Achenbach, P., Berge, T. V. D., Berner, R., Besser, R. E. J., Casteels, K., Larsson, H. E., Gemulla, G., Kordonouri, O., et al. (2023) · JAMA · doi:10.1001/jama.2023.16348 · Cited by 37 · see citing works
Leonard, M. T., Davis‐Richardson, A. G., Ardissone, A. N., Kemppainen, K. M., Drew, J. C., Ilonen, J., Knip, M., Simell, O., Toppari, J., Veijola, R., et al. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00361 · Cited by 36 · see citing works
Self-citationAllele-specific methylation of type 1 diabetes susceptibility genes
Kindt, A. S. D., Fuerst, R., Knoop, J., Laimighofer, M., Telieps, T., Hippich, M., Wörheide, M. A., Wahl, S., Wilson, R., Sedlmeier, E., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.11.008 · Cited by 36 · see citing works
Peptide serum markers in islet autoantibody-positive children
von Toerne, C., Laimighofer, M., Achenbach, P., Beyerlein, A., Gala, T. D. L. H., Krumsiek, J., Theis, F. J., Ziegler, A. G., & Hauck, S. M. (2016) · Diabetologia · doi:10.1007/s00125-016-4150-x · Cited by 35 · see citing works
Yeo, L., Pujol‐Autonell, I., Baptista, R., Eichmann, M., Kronenberg‐Versteeg, D., Heck, S., Dolton, G. M., Sewell, A. K., Härkönen, T., Mikk, M.-L., et al. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13391 · Cited by 35 · see citing works
Self-citationHeninger, A., Monti, P., Wilhelm, C., Schwaiger, P., Kuehn, D., Ziegler, A., & Bonifacio, E. E. (2013) · Diabetes · doi:10.2337/db12-0942 · Cited by 33 · see citing works
Role of humoral beta-cell autoimmunity in type 1 diabetes
Knip, M., Siljander, H., Ilonen, J., Simell, O., & Veijola, R. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12386 · Cited by 34 · see citing works
Self-citationIntestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children
Torun, A., Hupalowska, A., Trzonkowski, P., Kierkuś, J., & Pyrzyńska, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642166 · Cited by 34 · see citing works
Bonifacio, E. E., & Ziegler, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16354 · Cited by 33 · see citing works
A Key to T1D Prevention: Screening and Monitoring Relatives as Part of Clinical Care
Greenbaum, C. J. (2021) · Diabetes · doi:10.2337/db20-1112 · Cited by 32 · see citing works
Late-onset islet autoimmunity in childhood: the Diabetes Autoimmunity Study in the Young (DAISY)
Frohnert, B. I., Ide, L. M., Dong, F., Barón, A. E., Steck, A. K., Norris, J. M., & Rewers, M. (2017) · Diabetologia · doi:10.1007/s00125-017-4256-9 · Cited by 32 · see citing works
Beyerlein, A., Thiering, E., Pflueger, M., Bidlingmaier, M., Stock, J., Knopff, A., Winkler, C., Heinrich, J., & Ziegler, A. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12118 · Cited by 32 · see citing works
Ghalwash, M. F., Anand, V., Lou, O., Martin, F., Rewers, M., Ziegler, A., Toppari, J., Hagopian, W., Veijola, R., Achenbach, P., et al. (2023) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(22)00350-9 · Cited by 31 · see citing works
Self-citationGAD autoantibody affinity in schoolchildren from the general population
Bender, C., Schlosser, M., Christen, U., Ziegler, A. G., & Achenbach, P. (2014) · Diabetologia · doi:10.1007/s00125-014-3294-9 · Cited by 32 · see citing works
The countdown to type 1 diabetes: when, how and why does the clock start?
Ziegler, A.-G. (2023) · Diabetologia · doi:10.1007/s00125-023-05927-2 · Cited by 30 · see citing works
TEDDY study group, Köhler, M., Beyerlein, A., Vehik, K., Greven, S., Umlauf, N., Lernmark, Å., Hagopian, W., Rewers, M., She, J., et al. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-1033-7 · Cited by 30 · see citing works
Sjöblad, S. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.02.027 · Cited by 30 · see citing works
Čulina, S., Gupta, N., Boisgard, R., Afonso, G., Gagnerault, M. C., Dimitrov, J. D., Østerbye, T., Justesen, S. F. L., Luce, S., Attias, M., et al. (2015) · Diabetes · doi:10.2337/db15-0024 · Cited by 30 · see citing works
Current and Future Clinical Applications of Zinc Transporter-8 in Type 1 Diabetes Mellitus
Yi, B., Huang, G., & Zhou, Z. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.163389 · Cited by 29 · see citing works
Lessons and gaps in the prediction and prevention of type 1 diabetes
Mameli, C., Triolo, T. M., Chiarelli, F., Rewers, M., Zuccotti, G., & Simmons, K. M. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106792 · Cited by 32 · see citing works
Fouts, A., Pyle, L. L., Yu, L., Miao, D., Michels, A. W., Krischer, J. P., Sosenko, J. M., Gottlieb, P. A., Steck, A. K., & the Type 1 Diabetes TrialNet Study Group (2016) · Diabetes Care · doi:10.2337/dc16-0302 · Cited by 28 · see citing works
Early life origin of type 1 diabetes
Knip, M., Luopajärvi, K., & Härkönen, T. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0665-6 · Cited by 27 · see citing works
Self-citationEarly childhood CMV infection may decelerate the progression to clinical type 1 diabetes
Ekman, I., Vuorinen, T., Knip, M., Veijola, R., Toppari, J., Hyöty, H., Kinnunen, T. T., Ilonen, J., & Lempainen, J. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12788 · Cited by 27 · see citing works
Self-citationVecchio, F., Carré, A., Korenkov, D. A., Zhou, Z., Apaolaza, P. S., Tuomela, S., Morales, O. B., Snowhite, I. V., Perez-Hernandez, J., Brandao, B., et al. (2024) · Science Advances · doi:10.1126/sciadv.adl1122 · Cited by 27 · see citing works
Self-citationThe Changing Landscape of Type 1 Diabetes: Recent Developments and Future Frontiers
Vehik, K., Ajami, N., Hadley, D., Petrosino, J., & Burkhardt, B. R. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0406-8 · Cited by 25 · see citing works
Screening of ZnT8 autoantibodies in the diagnosis of autoimmune diabetes in a large French cohort
Garnier, L., Marchand, L., Benoit, M., Nicolino, M. P., Bendelac, N., Wright, C. C., Moulin, P., Lombard, C., Thivolet, C. H., & Fabien, N. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.12.043 · Cited by 26 · see citing works
New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes
Cabello-Olmo, M., Araña, M., Radichev, I., Smith, P., Huarte, E., & Barajas, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194789 · Cited by 27 · see citing works
Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How?
Deligne, C., You, S., & Mallone, R. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040542 · Cited by 25 · see citing works
Immune Intervention and Preservation of Pancreatic Beta Cell Function in Type 1 Diabetes
Simmons, K. M., Gottlieb, P. A., & Michels, A. W. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0793-8 · Cited by 25 · see citing works
The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes
Mader, J. K., Wong, J. C., Freckmann, G., Garcia‐Tirado, J., Hirsch, I. B., Johnson, S. B., Kerr, D. E., Kim, S. H., Lal, R., Montaser, E., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251333441 · Cited by 26 · see citing works
Till, A. ‐., Kenk, H., Rjasanowski, I. M., Waßmuth, R., Walschus, U., Kerner, W., & Schlosser, M. (2014) · Diabetic Medicine · doi:10.1111/dme.12677 · Cited by 25 · see citing works
Gu, Y., Merriman, C., Guo, Z., Jia, X., Wenzlau, J. M., Li, H., Li, H., Rewers, M., Yu, L., & Fu, D. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102677 · Cited by 24 · see citing works
Ye, Y., Vives‐Pi, M., & Gillespie, K. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086985 · Cited by 24 · see citing works
- Authors
- Parikka, V., Näntö-Salonen, K., Saarinen, M., Simell, T., Ilonen, J., Hyöty, H., Veijola, R., Knip, M., & Simell, O.
- Affiliations
- Turku University Hospital (FI)
- University of Turku (FI)
- Tampere University (FI)
- Oulu University Hospital (FI)
- University of Helsinki (FI)
- Corresponding author
- Parikka, V.
- Venue
- Diabetologia
- Published
- 2012-03-23
- Volume
- 55
- Issue
- 7
- Pages
- 1926-1936
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2049204060
- Cited by
- 235
- References
- 43
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 10 · 2023: 19 · 2022: 14 · 2021: 21 · 2020: 8 · 2019: 16 · 2018: 14 · 2017: 17 · 2016: 25 · 2015: 25 · 2014: 21 · 2013: 16 · 2012: 7
- FWCI
- 13.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Juvenile Diabetes Research Foundation International (4‐1998‐274, 4‐1999‐731, 68292, 4-1998-274, 4-1999-731, 4-2001-435, 4‐2001‐435)
- European Commission (BMH4‐CT98‐3314, 4-1998-274, 4-1999-731, 68292, 4-2001-435)
- Academy of Finland (114666, 68292)
- Suomen Kulttuurirahasto
- Tekes (4-1998-274, 68292, 4-1999-731, 4-2001-435)
- Päivikki ja Sakari Sohlbergin Säätiö (68292, 4-1998-274, 4-2001-435, 4-1999-731)
- Signe ja Ane Gyllenbergin Säätiö (4-1999-731, 4-2001-435, 4-1998-274, 68292)
- Emil Aaltosen Säätiö
- Lastentautien Tutkimussäätiö (BMH4- CT98-3314, 4-2001-435, 68292, 4-1998-274, 4-1999-731)
- Fonds Spéciaux de Recherche
- Varsinais-Suomen Rahasto
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Keywords
- type 1 diabetes, autoantibodies, seroconversion, prepubertal onset, islet autoimmunity, GAD65, insulin autoantibodies, disease progression prediction, autoantibody titres, early life events
- MeSH terms
- Autoantibodies, Child, Preschool, Diabetes Mellitus, Type 1, Disease Susceptibility, Female, Finland, HLA Antigens, Humans, Infant, Infant, Newborn, Male, Prediabetic State, Predictive Value of Tests, Pregnancy, Biomarkers, Age of Onset, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review